Status:
RECRUITING
Non-invasive Left-sided Cervical Vagus Nerve Stimulation for Atrioventricular Reentrant Tachycardia
Lead Sponsor:
Jingye Tai
Conditions:
Atrioventricular Reentrant Tachycardia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The goal of this Interventional clinical trials in atrioventricular reentrant tachycardia patients. The main question it aims to answer whether non-invasive vagus nerve stimulation could be effective ...
Detailed Description
Participants will be treated with non-invasive electrical stimulation of the left vagus nerve in the neck. After routine induction of atrioventricular reentrant tachycardia prior to radiofrequency abl...
Eligibility Criteria
Inclusion
- The relevant diagnostic criteria in the Guidelines for the Diagnosis and Treatment of Supraventricular Tachycardia (svt) need to be met.
- All need to be free of psychiatric abnormalities, verbal communication disorders, and have good compliance.
- The patients and their families gave informed consent and signed the informed consent form.
Exclusion
- Does not meet the relevant diagnostic criteria in the Guidelines for the Diagnosis and Treatment of Supraventricular Tachycardia (svt).
- Mental anomalies, verbal communication disorders, poor adherence
- Those who do not consent to participate in this clinical trial
Key Trial Info
Start Date :
January 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06219343
Start Date
January 10 2023
End Date
December 30 2024
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ai-lan Chen
Guangzhou, Guangdong, China, 510000